Neubase Therapeutics Stock Price, News & Analysis
Company Description
Neubase Therapeutics (NASDAQ: NBSE) is a publicly traded pharmaceutical preparation manufacturing company in the Pharmaceutical Preparations sector. The company has a market capitalization of $1.4M, ranking #7,015 among all listed U.S. companies by market cap.
NBSE stock has declined 100.0% over the past year. Shares last traded at $0.3780.
This page provides a comprehensive overview of NBSE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Neubase Therapeutics (NBSE) stock last traded at $0.3780. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $1.4M, NBSE is classified as a micro-cap stock with approximately 3.8M shares outstanding.
Latest News
Neubase Therapeutics has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition, private placement, offering, stock split, conferences. View all NBSE news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
NBSE Company Profile & Sector Positioning
Neubase Therapeutics (NBSE) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.